Sbi Securities Co., Ltd. Ovid Therapeutics Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 84 shares of OVID stock, worth $57. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84Holding current value
$57% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
74Shares Held
39MCall Options Held
37.4KPut Options Held
500-
Rubric Capital Management LP New York, NY5.32MShares$3.67 Million0.17% of portfolio
-
Madison Avenue Partners, LP New York, NY4.12MShares$2.84 Million0.6% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.75 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.66 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$2.17 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $48.6M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...